期刊文献+

可回复性肝细胞永生化载体pCTGTKlox的构建、鉴定、转染与表达 被引量:4

Construction,characterization,transfection and expression of vector pCTGTKlox for hepatocyte reversible immortalization
下载PDF
导出
摘要 目的构建可回复性永生化逆转录病毒载体,为肝细胞可回复性永生化奠定基础。方法扩增加强型绿色荧光蛋白(EGFP)及胸腺激酶(TK)并采用重叠延伸拼接法(SOE)连接EGFP和TK,将EGFP-TK融合基因亚克隆至pBABE-puro-lox,构建成新载体pBGTKlox,再将永生化基因SV40T连接至pBGTKlox,构成新载体pBTGTKlox,最后将雌激素受体与重组酶融合基因(Cre-ER)连接至pBTGTKlox,构成新载体pCTGTKlox。将pCTGTKlox和pPDF15质粒共转染包装细胞PT67,并在荧光显微镜下观察绿色荧光蛋白的表达。免疫组化染色检测SV40T基因的表达。结果成功构建包含EGFP-TK、SV40T、Cre-ER及重组序列loxP的新载体pCTGTKlox,经酶切鉴定证实为重组阳性体,经测序验证无核苷酸突变。pCTGTKlox转染PT67细胞24h后,荧光显微镜下可见散在多处绿色荧光。免疫组化染色显示细胞胞核呈阳性染色。结论成功构建并表达可回复性永生化逆转录病毒载体pCTGTKlox,为细胞的可回复性永生化提供了一种良好的新型载体。 Objective To establish a retreviral vectorfor reversible hepatocyte immollalization. Methods The enhanced green fluorence protein (EGFP) and thymokinase (TK) were amplified and fused. The fusion gene EGFP-TK was cloned to pBABE- puro-lox to construct pBGTKlox,then the immortalized SV40T was connected to the pBGTKlox to establish pBTGTKlox,and finally Cre-ER was connected to pBTGTKlox For establish pCTGTKlox. PT67 cells were co-transfected with pCTGTKlox and pPDF15 and the expresion of green fluorescence protein was observed under fluorence microscope. The steadily transfected cells were stained immunohistochemically to detect the expression of SV40 huge T antigen. Results A new vector pCTGTKlox containing Cre-ER,SV40T, EGFP-TK and LoxP was constructed and verified by restriction endonuclease digestion. DNA sequencing demonstrated that there was no coding mutation in pCTGTKlox. After co-transfection with pCTGTKlox and pPDF15, PT67 cells emitted green fluorescence under the fluorescence microscope. The nuclei of the transfected cells were positive For immunochemical staining. Concimion The reversible vector pCTGTKlox is successfully constructed and expressed,thus it provides an ideal vector in the reversible immortalization of hepatocytes and othermammalian cells.
出处 《生物医学工程与临床》 CAS 2006年第3期177-180,F0003,共5页 Biomedical Engineering and Clinical Medicine
基金 国家自然科学基金资助(编号:301000830370391)
关键词 逆转录病毒 载体 永生化肝细胞 回复 retrovirus vector immortalization hepatocytes reversion
  • 相关文献

参考文献15

  • 1Kobayashi N, Okitsu T, Nakaji S,et al. Hybrid bioartificial liver:establishing a reversibly immortalized hnman hepatocyte line and developing a bioartificial liver for practical use [J]. J Artif Organs, 2003,6 (4) :236-244.
  • 2Kobayashit N,Tanaka N. Engineering of human hepatocyte lines for cell therapies in humans: prospects and remaining hurdles[J]. Cell Transplant, 2002,11 (5) :417-420.
  • 3Bilir BM,Guinette D ,Karrer F, et al.Hepatocyte transplantation in acute liver failure[J]. Liver Transpl, 2000,6 (1) : 32-40.
  • 4Sato Y,Endo H,Ajiki T,et al.Establishment of Cre/LoxP recombination system in transgenic rats [J]. Biochem Biophys Res Commun ,2004,319(4) : 1197-1202.
  • 5Kobayashi N, Noguchi H, Fujiwara T,et al. Establishment of a reversibly immortalized human hepatocyte ceil line by using Cre/loxP site-specific recombination [J]. Transplant Proc,2000,32(5): 1121-1122.
  • 6Berghella L, De Angelis L, Coletta M ,et al. Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogene[J]. Hum Gene Ther, 1999,10(10):1607-1617.
  • 7Salmon P, Oberholzer J,0cchiodoro T,et al. Reversible immortolization of human primary cells by lentivector-mediated transfer of specific genes[J]. Mol Ther,2000,2(4) :404-414.
  • 8Kobayashi N,Noguchi H,Westerman KA,et al. Cre/loxP-based reversible immortalization of human hepatocytes [J]. Cell Transplant, 2001,10 (4-5) : 383-386.
  • 9李俊刚,陈耀凯,王宇明.SV40T外显子的拼接及逆转录病毒载体pLLTSN的构建[J].世界华人消化杂志,2004,12(5):1104-1107. 被引量:3
  • 10Min Kim J,Young Choi J,Sun Kim M,et al. In vivo excision and amplification of large human genomic segments using the Cre/loxP-and large T antigen/SV40 ori-mediated machinery[J]. J Biotechnol, 2004,110(3) : 227-233.

二级参考文献28

  • 1Xiao-Ping Chen~2 Yi-Long Xue~1 Xin-Jian Li~1 Zuo-Yun Zhang~1 Yan-Ling Li~1 Zhi-Qiang Huang~2 1 Institute of Basic Medical Sciences,2 Department of Hepatobiliary Surgery,PLA General Hospital,Beijing 100853,China.Experimental research on TECA-I bioartificial liver support system to treat canines with acute liver failure[J].World Journal of Gastroenterology,2001,7(5):706-709. 被引量:17
  • 2XUE Yi Long 1, ZHAO Shi Feng 2, ZHANG Zuo Yun 1, WANG Yue Feng 1, LI Xin Jian 1, HUANG Xiao Qiang 3, LUO Yun 1, HUANG Ying Cai 4 and LIU Cheng Gui 1.Effects of a bioartificial liver support system on acetaminophen induced acute liver failure canines[J].World Journal of Gastroenterology,1999,5(4):36-39. 被引量:19
  • 3Jauregui HO. The technology of biological extracorporeal liver assist devices: from infancy to adolescence. Artif Organs 1997;21:1163-1168.
  • 4Bilir BM, Guinette D, Karrer F, Kumpe DA, Krysl J, Stephens J, McGavran L, Ostrowska A, Durham J. Hepatocyte transplantation in acute liver failure. Liver Transpl 2000;6:32-40.
  • 5Davenport A. Artificial hepatic support. Where are we now?Blood Purif 2001;19:1-3.
  • 6Kobayashi N, Okitsu T, Nakaji S, Tanaka N. Hybrid bioartificial liver:establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use. J Artif Organs 2003;6:236-244.
  • 7Tsiaoussis J, Newsome PN, Nelson LJ, Hayes PC, Plevris JN.Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl 2001;7:2-10.
  • 8Kono Y, Yang S, Letarte M, Roberts EA. Establishment of a human hepatocyte line derived from primary culture in a collagen gel sandwich culture system. Exp Cell Res 1995;221:478-485.
  • 9Werner A, Duvar S, Muthing J, Buntemeyer H, Kahmann U,Lunsdorf H, Lehmann J. Cultivation and characterization of a new immortalized human hepatocyte cell line, HepZ, for use in an artificial liver support system. Ann N Y Acad Sci 1999;875:364-368.
  • 10Wege H, Le HT, Chui MS, Liu L, Wu J, Giri R, Malhi H, Sappal BS, Kumaran V, Gupta S, Zero MA. Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential. Gastroenterology 2003;124:432-444.

共引文献3

同被引文献44

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部